Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

HIV Related Lymphoma


Affiliations
1 Lotus Institute of Haematology, Oncology and Bone Marrow Transplantation, Nashik, India
     

   Subscribe/Renew Journal


Lymphoma is common in patients with HIV/AIDS. High grade lymphomas are more common than in non-HIV population. Early diagnosis is important and may coexist with other opportunistic infections which also occur in this population. CNS lymphoma is more common and needs to be diagnosed early. CNS prophylaxis is needed in most of this patients, as they are high grade with stage IV disease. Concomitant HAART therapy is must and has improved the prognosis and reduced infections. Aggressive chemotherapy regimens should be used with antibacterial, antiviral and anti-pneumocystis prophylaxis. Rituximab has been used extensively. Opportunistic infections have to be monitored closely while using Rituximab. Stem cell transplantation has to be applied as in Non-HIV patients and there are atleast two large series of its use in HIV/AIDS population.

Keywords

HIV, AIDS, Lymphoma, HAART, Rituximab.
Subscription Login to verify subscription
User
Notifications
Font Size


Abstract Views: 249

PDF Views: 0




  • HIV Related Lymphoma

Abstract Views: 249  |  PDF Views: 0

Authors

Pritesh Junagade
Lotus Institute of Haematology, Oncology and Bone Marrow Transplantation, Nashik, India

Abstract


Lymphoma is common in patients with HIV/AIDS. High grade lymphomas are more common than in non-HIV population. Early diagnosis is important and may coexist with other opportunistic infections which also occur in this population. CNS lymphoma is more common and needs to be diagnosed early. CNS prophylaxis is needed in most of this patients, as they are high grade with stage IV disease. Concomitant HAART therapy is must and has improved the prognosis and reduced infections. Aggressive chemotherapy regimens should be used with antibacterial, antiviral and anti-pneumocystis prophylaxis. Rituximab has been used extensively. Opportunistic infections have to be monitored closely while using Rituximab. Stem cell transplantation has to be applied as in Non-HIV patients and there are atleast two large series of its use in HIV/AIDS population.

Keywords


HIV, AIDS, Lymphoma, HAART, Rituximab.